Ipswich Investment Management Co., Inc. Gilead Sciences, Inc. Transaction History

Ipswich Investment Management Co., Inc.

$419 Million
Q3 2024

A detailed history of Ipswich Investment Management Co., Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ipswich Investment Management Co., Inc. holds 4,665 shares of GILD stock, worth $438,276. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,665

Previous 4,665 -0.0%

Holding current value

$438,276

Previous $320,000 22.19%

% of portfolio

0.09%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$63.15 - $72.88 $2,526 - $2,915	-40 Reduced 0.85%	4,665 $320,000
Q4 2023 Jan 31, 2024	SELL	$73.27 - $83.09 $18,317 - $20,772	-250 Reduced 5.05%	4,705 $381,000
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $18,485 - $20,167	-250 Reduced 4.8%	4,955 $371,000
Q2 2023 Jul 27, 2023	SELL	$76.01 - $86.7 $17,102 - $19,507	-225 Reduced 4.14%	5,205 $401,000
Q1 2023 Apr 24, 2023	BUY	$77.31 - $88.08 $4,638 - $5,284	60 Added 1.12%	5,430 $450,000
Q4 2022 Feb 01, 2023	BUY	$62.32 - $89.47 $1,246 - $1,789	20 Added 0.37%	5,370 $461,000
Q3 2022 Oct 11, 2022	BUY	$59.54 - $68.01 $15,182 - $17,342	255 Added 5.0%	5,350 $330,000
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $8,109 - $9,205	-125 Reduced 2.39%	5,095 $370,000
Q3 2021 Oct 07, 2021	SELL	$67.69 - $73.03 $18,953 - $20,448	-280 Reduced 5.09%	5,220 $365,000
Q1 2021 Apr 09, 2021	BUY	$60.0 - $68.46 $60,000 - $68,460	1,000 Added 22.22%	5,500 $355,000
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $33,990 - $38,730	-600 Reduced 11.76%	4,500 $262,000
Q3 2020 Oct 06, 2020	SELL	$62.1 - $78.08 $3,415 - $4,294	-55 Reduced 1.07%	5,100 $322,000
Q2 2020 Jul 09, 2020	SELL	$72.34 - $84.0 $223,964 - $260,064	-3,096 Reduced 37.52%	5,155 $397,000
Q1 2020 Apr 09, 2020	BUY	$62.63 - $80.22 $6,263 - $8,022	100 Added 1.23%	8,251 $617,000
Q4 2019 Jan 08, 2020	SELL	$61.62 - $67.78 $17,253 - $18,978	-280 Reduced 3.32%	8,151 $530,000
Q2 2019 Jul 11, 2019	SELL	$61.87 - $69.38 $1,856 - $2,081	-30 Reduced 0.35%	8,431 $570,000
Q1 2019 Apr 12, 2019	SELL	$62.53 - $70.05 $3,126 - $3,502	-50 Reduced 0.59%	8,461 $550,000
Q4 2018 Jan 15, 2019	SELL	$60.54 - $79.0 $1,513 - $1,975	-25 Reduced 0.29%	8,511 $532,000
Q3 2018 Oct 09, 2018	BUY	$71.28 - $78.92 $608,446 - $673,661	8,536 New	8,536 $659,000
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $553,815 - $646,004	-8,536 Closed	0 $0
Q1 2018 Apr 12, 2018	SELL	$72.84 - $88.8 $2,185 - $2,664	-30 Reduced 0.35%	8,536 $644,000
Q4 2017 Jan 16, 2018	BUY	$71.15 - $83.52 $24,191 - $28,396	340 Added 4.13%	8,566 $614,000
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $593,176 - $703,076	8,226	8,226 $666,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.

Account

Ipswich Investment Management Co., Inc. Gilead Sciences, Inc. Transaction History